Nirvana Life Sciences Inc. (NIRV.CN) Research

Nirvana Life Sciences Inc. specializes in the scientific investigation and creation of therapeutic offerings derived from psychedelics. Additionally, the company is engaged in pioneering methods for the isolation and purification of psychoactive compounds, as well as advancing cultivation techniques to enable large-scale growth of the relevant biological material. The organization was founded in 2020 and maintains its principal office in Vancouver, Canada.

Market snapshot

Symbol
NIRV.CN
Price
$0.07
Day change
0.00%
Market cap
$337.6K
P/E ratio
-5.60x
52-week range
0.03-0.5
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Albert Labs International Corp. (ABRT.CN)
  • Aquarius Surgical Technologies Inc. (ASTI.CN)
  • Bioasis Technologies Inc. (BTI.V)
  • ChitogenX Inc. (CHGX.CN)
  • Biocure Technology Inc. (CURE.CN)
  • Restart Life Sciences Corp. (HEAL.CN)
  • Lowell Farms Inc. (LOWL.CN)
  • NanoSphere Health Sciences Inc. (NSHS.CN)

Open Nirvana Life Sciences Inc. (NIRV.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.